Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial. [electronic resource]
Producer: 20210628Description: 306-314 p. digitalISSN:- 1473-5830
- Computed Tomography Angiography
- Coronary Angiography
- Coronary Artery Disease -- complications
- Diabetes Mellitus, Type 2 -- complications
- Disease Progression
- Glucagon-Like Peptides -- therapeutic use
- Humans
- Incretins -- therapeutic use
- Plaque, Atherosclerotic -- complications
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Vascular Calcification -- complications
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.